Dr. David Chan, M.D.
Claim this profileTorrance Memorial Physician Network / Cancer Care
Studies Breast Cancer
Studies Pancreatic Cancer
16 reported clinical trials
28 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage I
Stage II
2Pancreatic Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials David Chan, M.D. is currently running
Tart Cherry + Fish Oil
for Joint Pain
Both Tart Cherry and Omega 3 FAs have better side effect profiles compared to other commonly used medications for AIMSS, such as nonsteroidal anti-inflammatories, steroids, and serotonin norepinephrine reuptake inhibitors. Additionally, in our clinics we often find that patients tend to be more receptive to taking a supplement as opposed to an additional medication. Further, both Tart Cherry concentrate and fish oil have beneficial properties for helping with joint stiffness in general, in addition to other health issues like insomnia. There is preliminary evidence in mouse models that when given together, these supplements may have an even greater anti-inflammatory effect than when taken separately14. Although to our knowledge, no human studies have tested this hypothesis. This study has been designed to test the hypothesis that Tart Cherry and fish oil when given in combination over a 12-week period could produce beneficial changes in joint function when compared to Tart Cherry or fish oil in isolation in an obese breast cancer population experiencing AIMSS. Secondary outcomes to be assessed include pain, functional performance, quality of life and cognition.
Recruiting1 award Phase < 18 criteria
Cisplatin
for Oropharyngeal Cancer
This is a single institution phase II study that will enroll patients with T0-3N0-2 p16-positive oropharyngeal squamous cell carcinoma (OSCC) undergoing resection of all gross visible disease at the primary site and in the lymph nodes.
Recruiting1 award Phase 27 criteria
More about David Chan, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments David Chan, M.D. has experience with
- Placebo
- Anastrozole
- Abemaciclib
- Imlunestrant
- Tamoxifen
- Letrozole
Breakdown of trials David Chan, M.D. has run
Breast Cancer
Neuroendocrine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Chan, M.D. specialize in?
David Chan, M.D. focuses on Breast Cancer and Pancreatic Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage I.
Is David Chan, M.D. currently recruiting for clinical trials?
Yes, David Chan, M.D. is currently recruiting for 5 clinical trials in Torrance California. If you're interested in participating, you should apply.
Are there any treatments that David Chan, M.D. has studied deeply?
Yes, David Chan, M.D. has studied treatments such as Placebo, Anastrozole, Abemaciclib.
What is the best way to schedule an appointment with David Chan, M.D.?
Apply for one of the trials that David Chan, M.D. is conducting.
What is the office address of David Chan, M.D.?
The office of David Chan, M.D. is located at: Torrance Memorial Physician Network / Cancer Care, Torrance, California 90505 United States. This is the address for their practice at the Torrance Memorial Physician Network / Cancer Care.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.